- Home
- SW vs BNTX Comparison
SW vs BNTX Comparison
Compare SW & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SW | BNTX |
|---|---|---|
| Founded | 1934 | 2008 |
| Country | Ireland | Germany |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SW | BNTX |
|---|---|---|
| Price | $38.70 | $94.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | $53.55 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 4.9M | 1.5M |
| Earning Date | 02-11-2026 | 11-03-2025 |
| Dividend Yield | ★ 4.44% | N/A |
| EPS Growth | ★ 109.82 | N/A |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $31,138,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $52.96 | $2.03 |
| Revenue Next Year | $2.73 | N/A |
| P/E Ratio | $27.34 | ★ N/A |
| Revenue Growth | ★ 89.50 | 3.70 |
| 52 Week Low | $32.73 | $81.20 |
| 52 Week High | $56.05 | $129.27 |
Technical Indicators
Market Signals| Indicator | SW | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.13 | 45.36 |
| Support Level | $37.53 | $94.00 |
| Resistance Level | $38.92 | $95.71 |
| Average True Range (ATR) | 0.70 | 1.74 |
| MACD | 0.17 | 0.51 |
| Stochastic Oscillator | 84.82 | 60.42 |
Price Performance
Historical ComparisonAbout SW Smurfit WestRock plc Ordinary Shares
Smurfit WestRock manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. After the merger of Smurfit Kappa and WestRock in summer 2024, Smurfit WestRock became the largest producer of containerboard in the world, with substantial operations in North America, South America, and Europe.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.